Mycophenolate
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Mycophenolate. Multifocal motor neuropathy (MMN), Polymyositis, Myasthenia gravis (MG). Fully referenced neurology checklist.
Indications
- Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
- Multifocal motor neuropathy (MMN)
- Polymyositis
- Myasthenia gravis (MG)
Contraindications
Locked: subscribe to see this section.
Dose
Locked: subscribe to see this section.
Precautions
Locked: subscribe to see this section.
Monitoring blood tests
Locked: subscribe to see this section.
Monitoring frequency
Locked: subscribe to see this section.
Monitoring: others
Locked: subscribe to see this section.
Indications for stopping
Locked: subscribe to see this section.
References
- Gorson KC, Amato AA, Ropper AH. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy. Neurology 2004; 63:715-717.
- Chaudhry V, Cornblath DR, Griffin JW, O'Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001; 56:94-96.
- Piepers S, Van den Berg-Vos R, Van der Pol WL, Franssen H, Wokke J, Van den Berg L. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain 2007; 130:2004-2010.
- Pisoni CN, Cuadrado MJ, Khamashta MA, Hughes GR, D'Cruz DP. Mycophenolate mofetil treatment in resistant myositis. Rheumatology (Oxford) 2007; 46:516-518.
- Majithia V, Harisdangkul V. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology (Oxford) 2005; 44:386-389.
- And 6 more. Subscribe to see the full list
